Tuesday, October 29, 2013

Cardiac Monitoring Market worth $23.3 Billion - 2017

The “Healthcare” practice at MarketsandMarkets is pleased to announce its Analyst Briefing Presentation on the “Cardiac Monitoring & Cardiac Rhythm Management (CRM) Market [ECG, Implantable Loop Recorder, Holter, Implantable Cardioverter Defibrillator (ICD), Automated External Defibrillator (AED), Pacemaker, CRT-D, CRT- P] - Global Forecasts to 2017” to be held on 11 February 2013

Browse:
  • 144 tables 
  • 23 figures
  • 334 pages combined with an in-depth TOC on "Cardiac Monitoring & Cardiac Rhythm Management (CRM) Market" [ECG, Implantable Loop Recorder, Holter, Implantable Cardioverter Defibrillator (ICD), Automated External Defibrillator (AED), Pacemaker, CRT-D, CRT- P] - Global Forecasts to 2017”.
http://www.marketsandmarkets.com/Market-Reports/cardiac-monitoring-advanced-technologies-and-global-market-55.html
Early buyers will receive 10% customization on this report.
To buy this report click here:

Cardiac Monitoring and Cardiac Rhythm Management Market was worth $18.4 billion in the year 2012. The market will grow at a healthy pace in the next five years due to the increasing incidence of cardiovascular diseases, technological advancement, rising cost of cardiac disease treatment, and government regulations in favor of cardiac monitoring.

The key players in the cardiac monitoring and cardiac rhythm management market are Boston Scientific (U.S.),Cardiac Science Corporation (U.S.), CardioNet (U.S.), GE Healthcare (U.K.), LifeWatch (Switzerland), Medtronic (U.S.), Mortara Instruments (U.S.), Philips Healthcare (The Netherlands), Schiller (Switzerland), Spacelabs Healthcare (U.S.), St. Jude Medical (U.S.), Welch Allyn (U.S.), and Zoll Medical Corporation (U.S.).

Increasing incidence of cardiovascular diseases, technological advancement, rising cost of cardiac disease treatment, and government regulations in favor of cardiac monitoring are accelerating the growth of conventional monitors as well as CRM devices. However, the economic slowdown and unstable reimbursement policies will hamper the growth of this market, to a certain extent.

The geographies covered in this study are North America, Europe, Asia, and Rest of the World (RoW). These four regions are further segmented by major countries, and geographic split for all the sub-segments is presented at a regional level. North America is the largest market for cardiac monitoring and cardiac rhythm management devices, followed by Europe and Asia. North America and Europe are expected to grow at a slower pace, primarily due to the economic slowdown and market maturity. The Asian market, especially India and China, is expected to witness a boost in demand for cardiac monitoring and CRM products, and is poised to register maximum growth over the next five years, owing to the rising incidence of cardiovascular diseases and increased purchasing power of patients.

@Source: MarketsandMarkets

Post a Comment